Stratos Wealth Partners’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $585K | Sell |
1,042
-72
| -6% | -$46.2K | 0.01% | 1006 |
|
|
2025
Q4 | $754K | Buy |
1,114
+45
| +4% | +$30.6K | 0.01% | 877 |
|
|
2025
Q3 | $683K | Buy |
1,069
+18
| +2% | +$10.9K | 0.01% | 899 |
|
|
2025
Q2 | $564K | Buy |
1,051
+18
| +2% | +$8.61K | 0.01% | 884 |
|
|
2025
Q1 | $434K | Sell |
1,033
-356
| -26% | -$155K | 0.01% | 941 |
|
|
2024
Q4 | $574K | Sell |
1,389
-76
| -5% | -$33.3K | 0.01% | 879 |
|
|
2024
Q3 | $740K | Buy |
1,465
+252
| +21% | +$122K | 0.01% | 788 |
|
|
2024
Q2 | $591K | Buy |
1,213
+45
| +4% | +$22.6K | 0.01% | 838 |
|
|
2024
Q1 | $631K | Sell |
1,168
-47
| -4% | -$25.7K | 0.01% | 802 |
|
|
2023
Q4 | $674K | Hold |
1,215
| – | – | 0.01% | 763 |
|
|
2023
Q3 | $531K | Buy |
1,215
+1
| +0.1% | +$499 | 0.01% | 802 |
|
|
2023
Q2 | $610K | Buy |
1,214
+5
| +0.4% | +$2.4K | 0.01% | 696 |
|
|
2023
Q1 | $605K | Buy |
1,209
+18
| +2% | +$8.61K | 0.02% | 632 |
|
|
2022
Q4 | $486K | Buy |
1,191
+64
| +6% | +$24.8K | 0.01% | 744 |
|
|
2022
Q3 | $367K | Sell |
1,127
-400
| -26% | -$147K | 0.01% | 797 |
|
|
2022
Q2 | $536K | Sell |
1,527
-6
| -0.4% | -$2.45K | 0.01% | 704 |
|
|
2022
Q1 | $839K | Buy |
1,533
+74
| +5% | +$38.9K | 0.02% | 620 |
|
|
2021
Q4 | $961K | Buy |
1,459
+117
| +9% | +$73.4K | 0.02% | 571 |
|
|
2021
Q3 | $835K | Buy |
1,342
+32
| +2% | +$21.5K | 0.02% | 575 |
|
|
2021
Q2 | $827K | Buy |
1,310
+6
| +0.5% | +$3.31K | 0.02% | 595 |
|
|
2021
Q1 | $638K | Sell |
1,304
-73
| -5% | -$36.6K | 0.02% | 633 |
|
|
2020
Q4 | $688K | Buy |
1,377
+8
| +0.6% | +$3.58K | 0.02% | 566 |
|
|
2020
Q3 | $538K | Hold |
1,369
| – | – | 0.02% | 597 |
|
|
2020
Q2 | $452K | Hold |
1,369
| – | – | 0.02% | 633 |
|
|
2020
Q1 | $332K | Sell |
1,369
-263
| -16% | -$68.6K | 0.02% | 657 |
|
|
2019
Q4 | $426K | Buy |
1,632
+197
| +14% | +$51.9K | 0.02% | 639 |
|
|
2019
Q3 | $390K | Sell |
1,435
-230
| -14% | -$64K | 0.02% | 640 |
|
|
2019
Q2 | $458K | Buy |
1,665
+1
| +0.1% | +$246 | 0.02% | 604 |
|
|
2019
Q1 | $372K | Sell |
1,664
-200
| -11% | -$41.3K | 0.02% | 639 |
|
|
2018
Q4 | $347K | Sell |
1,864
-2,669
| -59% | -$547K | 0.02% | 625 |
|
|
2018
Q3 | $1.13M | Buy |
4,533
+380
| +9% | +$92.2K | 0.05% | 309 |
|
|
2018
Q2 | $905K | Sell |
4,153
-503
| -11% | -$104K | 0.04% | 386 |
|
|
2018
Q1 | $891K | Buy |
4,656
+3,192
| +218% | +$589K | 0.04% | 390 |
|
|
2017
Q4 | $229K | Hold |
1,464
| – | – | 0.01% | 816 |
|
|
2017
Q3 | $228K | Sell |
1,464
-98
| -6% | -$15.5K | 0.01% | 798 |
|
|
2017
Q2 | $252K | Sell |
1,562
-11
| -0.7% | -$1.79K | 0.01% | 703 |
|
|
2017
Q1 | $243K | Buy |
+1,573
| New | +$217K | 0.01% | 652 |
|
Other funds holding IDXX
VCM
VPM
Stratos Wealth Partners's IDXX Position: Q1 2026 in Review
Stratos Wealth Partners reduced its Idexx Laboratories (IDXX) stake by 6.5% in Q1 2026, selling an estimated $46.2K and leaving 1,042 shares worth $585K. The position accounts for 0.01% of the portfolio, ranked #1006.
Stratos Wealth Partners first reported a position in IDXX in Q1 2017 and has held it in 37 quarters since. The position peaked at $1.13M in Q3 2018. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Stratos Wealth Partners held 1,042 shares of Idexx Laboratories worth $585K as of Q1 2026.
- Stratos Wealth Partners sold 72 Idexx Laboratories shares in Q1 2026, an estimated $46.2K.
- Idexx Laboratories made up 0.01% of Stratos Wealth Partners's portfolio in Q1 2026, its #1006 holding.
- Stratos Wealth Partners first reported a position in Idexx Laboratories in Q1 2017 and has held it in 37 quarters since.
- Stratos Wealth Partners's Idexx Laboratories position peaked at $1.13M in Q3 2018.
- 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Stratos Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.